Biocartis: Gina Wallar, Judith Vacchino

Molecular diagnostics firm Biocartis has appointed Gina Wallar as chief business officer and Judith Vacchino as VP of global marketing.

Wallar previously served as chief commercial officer at Flagship Biosciences. Prior to that, she was senior VP and general manager at Fulgent Genetics. She has also previously served as president of the pharma services division at NeoGenomics. Wallar holds a master's degree in epidemiology and biostatistics from Boston University and a PhD in cancer epidemiology from the University of California, Los Angeles.

Vacchino was previously senior director of product marketing at Grail. She also previously spent nearly 15 years at Genomic Health, where she helped drive the adoption of the Oncotype DX Breast Recurrence Score. After Genomic Health was acquired by Exact Sciences in 2019, Vacchino was appointed as senior director of HCP marketing for oncology and urology products at Exact. She holds a bachelor's degree in chemistry from Rutgers University and a PhD in biophysical chemistry from Stanford University.